Free Trial

Editas Medicine (EDIT) Short Interest Ratio & Short Volume

Editas Medicine logo
$1.21 -0.04 (-3.20%)
(As of 12/24/2024 05:19 PM ET)

Editas Medicine Short Interest Data

Editas Medicine (EDIT) has a short interest of 16.06 million shares. This marks a 0.94% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.2, indicating that it would take 7.2 days of the average trading volume of 2.05 million shares to cover all short positions.

Current Short Interest
16,060,000 shares
Previous Short Interest
15,910,000 shares
Change Vs. Previous Month
+0.94%
Dollar Volume Sold Short
$35.97 million
Short Interest Ratio
7.2 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
82,548,000 shares
Percentage of Shares Shorted
19.46%
Today's Trading Volume
1,580,551 shares
Average Trading Volume
2,050,229 shares
Today's Volume Vs. Average
77%
Short Selling Editas Medicine?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Editas Medicine and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EDIT Short Interest Over Time

EDIT Days to Cover Over Time

EDIT Percentage of Float Shorted Over Time

Editas Medicine Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/202416,060,000 shares $35.97 million +0.9%N/A7.2 $2.24
11/15/202415,910,000 shares $42.32 million -7.7%N/A7.4 $2.66
10/31/202417,240,000 shares $50.00 million -6.0%N/A8.8 $2.90
10/15/202418,330,000 shares $61.59 million +9.5%N/A9.9 $3.36
9/30/202416,740,000 shares $57.08 million -11.7%N/A9.3 $3.41
9/15/202418,960,000 shares $74.89 million +5.3%N/A10.5 $3.95
8/31/202418,010,000 shares $67.36 million +6.6%N/A9.4 $3.74
8/15/202416,900,000 shares $67.60 million +4.8%N/A8.5 $4.00
7/31/202416,130,000 shares $87.26 million +2.2%N/A7.7 $5.41
7/15/202415,790,000 shares $88.58 million -5.7%N/A7.6 $5.61
6/30/202416,740,000 shares $78.18 million -22.9%N/A8 $4.67
6/15/202421,700,000 shares $109.80 million -1.5%N/A10.6 $5.06
5/31/202422,020,000 shares $114.50 million +6.1%N/A11.7 $5.20
5/15/202420,760,000 shares $124.56 million +1.3%N/A10.3 $6.00
4/30/202420,500,000 shares $106.81 million +9.3%N/A10.3 $5.21
4/15/202418,760,000 shares $114.06 million +14.7%N/A9.8 $6.08
3/31/202416,360,000 shares $121.39 million +17.4%N/A8.9 $7.42
3/15/202413,930,000 shares $113.25 million +3.0%N/A7.5 $8.13
2/29/202413,520,000 shares $136.01 million +7.4%N/A7 $10.06
2/15/202412,590,000 shares $104.62 million +3.1%N/A7.2 $8.31
1/31/202412,210,000 shares $85.84 million -2.2%N/A6.7 $7.03
1/15/202412,480,000 shares $113.19 million -2.4%N/A6.8 $9.07
12/31/202312,790,000 shares $129.56 million -14.6%N/A7 $10.13
12/15/202314,970,000 shares $163.62 million -5.1%N/A7.7 $10.93
11/30/202315,780,000 shares $166.16 million -0.6%N/A8.9 $10.53
11/15/202315,870,000 shares $140.29 million -5.4%N/A9.7 $8.84
10/31/202316,770,000 shares $112.02 million +2.1%N/A11 $6.68
10/15/202316,420,000 shares $115.76 million +2.8%N/A11.2 $7.05
9/30/202315,970,000 shares $124.57 million +5.2%N/A11.1 $7.80
9/15/202315,180,000 shares $127.36 million +4.7%N/A10.8 $8.39
8/31/202314,500,000 shares $129.20 million +0.6%N/A8.1 $8.91
8/15/202314,410,000 shares $126.23 million -6.7%N/A7.5 $8.76
7/31/202315,440,000 shares $135.56 million -0.2%N/A7.5 $8.78
7/15/202315,470,000 shares $133.20 million -20.4%N/A7.4 $8.61
6/30/202319,430,000 shares $159.91 million -5.8%N/A8.6 $8.23
6/15/202320,630,000 shares $191.45 million +0.6%N/A9 $9.28
5/31/202320,500,000 shares $188.19 million +1.3%N/A11 $9.18
5/15/202320,230,000 shares $202.50 million +7.3%N/A11 $10.01
4/30/202318,860,000 shares $153.90 million -5.5%N/A10.7 $8.16
4/15/202319,950,000 shares $151.42 million +1.5%N/A11.1 $7.59
First JFK… next Elon? (Ad)

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.
3/31/202319,650,000 shares $142.46 million -4.8%N/A11.3 $7.25
3/15/202320,640,000 shares $174.00 million +7.7%N/A11.9 $8.43
2/28/202319,160,000 shares $173.21 million -2.6%N/A10 $9.04
2/15/202319,670,000 shares $203.78 million -6.1%N/A10.2 $10.36
1/31/202320,940,000 shares $207.10 million -5.4%N/A10.5 $9.89
1/15/202322,140,000 shares $186.64 million +2.3%N/A11.8 $8.43
12/30/202221,650,000 shares $192.04 million +2.3%N/A12 $8.87
12/15/202221,170,000 shares $211.91 million +7.7%N/A12.3 $10.01
11/30/202219,650,000 shares $208.29 million +4.0%N/A11.7 $10.60
11/15/202218,900,000 shares $246.65 million +2.3%N/A12.1 $13.05
10/31/202218,470,000 shares $231.80 million -0.4%N/A12.1 $12.55
10/15/202218,540,000 shares $210.99 million +2.2%N/A11.8 $11.38
9/30/202218,150,000 shares $222.16 million +5.3%N/A11 $12.24
9/15/202217,240,000 shares $277.74 million +3.4%N/A10.1 $16.11
8/31/202216,680,000 shares $245.20 million +2.7%N/A9.6 $14.70
8/15/202216,250,000 shares $299.98 million -3.1%N/A9.3 $18.46
7/31/202216,770,000 shares $266.81 million +2.4%N/A9.5 $15.91
7/15/202216,380,000 shares $245.54 million +7.0%N/A9.3 $14.99
6/30/202215,310,000 shares $181.12 million +4.7%N/A9 $11.83
6/15/202214,620,000 shares $153.95 million +1.3%N/A8.8 $10.53
5/31/202214,430,000 shares $164.36 million +10.2%N/A9.1 $11.39
5/15/202213,090,000 shares $155.38 million +3.7%N/A7.7 $11.87
4/30/202212,620,000 shares $167.09 million +0.9%N/A7.3 $13.24
4/15/202212,510,000 shares $208.54 million +1.8%N/A6.9 $16.67
3/31/202212,290,000 shares $233.76 million +4.0%N/A6.5 $19.02
3/15/202211,820,000 shares $176.24 million +3.2%N/A6.3 $14.91
2/28/202211,450,000 shares $196.02 million +3.1%N/A6.1 $17.12
2/15/202211,110,000 shares $184.98 million +1.3%N/A6.1 $16.65
1/31/202210,970,000 shares $208.87 million -3.2%N/A6.5 $19.04
1/15/202211,330,000 shares $250.39 million -0.6%N/A7.8 $22.10
12/31/202111,400,000 shares $302.67 million +5.3%N/A8.8 $26.55
12/15/202110,830,000 shares $324.25 million +9.7%N/A6.9 $29.94
11/30/20219,870,000 shares $322.35 million +3.5%N/A6.7 $32.66
11/15/20219,540,000 shares $343.34 million -4.3%N/A6.4 $35.99
10/29/20219,970,000 shares $366.10 million -1.9%N/A6 $36.72
10/15/202110,160,000 shares $386.28 million +47.3%N/A5.8 $38.02
9/30/20216,900,000 shares $283.45 million -1.4%N/A3.9 $41.08
9/15/20217,000,000 shares $422.10 million +3.4%N/A3.5 $60.30
8/31/20216,770,000 shares $430.50 million -9.7%N/A3.5 $63.59
8/13/20217,500,000 shares $469.95 million -11.7%N/A4 $62.66
7/30/20218,490,000 shares $355.39 million +1.9%N/A4.7 $41.86
7/15/20218,330,000 shares $349.78 million -20.1%12.3%5 $41.99
6/30/202110,430,000 shares $590.76 million +0.6%15.4%5.9 $56.64
6/15/202110,370,000 shares $363.99 million -2.4%15.3%8 $35.10
5/28/202110,620,000 shares $360.55 million +0.9%15.7%7.9 $33.95
5/14/202110,530,000 shares $330.64 million +1.0%N/A6.2 $31.40
4/30/202110,430,000 shares $389.77 million +1.8%N/A5.3 $37.37
4/15/202110,250,000 shares $425.68 million +0.4%N/A4.7 $41.53
3/31/202110,210,000 shares $413.51 million -3.8%N/A4.1 $40.50
3/15/202110,610,000 shares $491.03 million -6.2%N/A3.7 $46.28
First JFK… next Elon? (Ad)

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.
2/26/202111,310,000 shares $506.24 million +14.9%N/A3.5 $44.76
2/12/20219,840,000 shares $562.55 million +9.1%N/A3.3 $57.17
1/29/20219,020,000 shares $551.39 million -5.1%N/A3.4 $61.13
1/15/20219,500,000 shares $721.24 million -3.9%N/A3.9 $75.92
12/31/20209,890,000 shares $756.59 million -9.2%N/A4.8 $76.50
12/15/202010,890,000 shares $669.63 million -1.5%N/A6.4 $61.49
11/30/202011,060,000 shares $346.62 million -1.7%N/A10.2 $31.34
11/15/202011,250,000 shares $328.84 million -0.4%N/A12.9 $29.23
10/30/202011,290,000 shares $370.26 million -0.1%N/A13.6 $32.80
10/15/202011,300,000 shares $363.41 million +7.9%N/A12.7 $32.16
9/30/202010,470,000 shares $293.79 million +7.5%N/A11.9 $28.06
9/15/20209,740,000 shares $310.71 million +6.2%N/A9.7 $31.90
8/31/20209,170,000 shares $323.06 million -0.7%N/A8.5 $35.23
8/14/20209,230,000 shares $322.31 million +4.5%N/A8.5 $34.92
7/31/20208,830,000 shares $259.25 million -0.5%N/A7.7 $29.36
7/15/20208,870,000 shares $289.34 million -5.6%N/A8.2 $32.62
6/30/20209,400,000 shares $278.05 million +3.5%N/A9 $29.58
6/15/20209,080,000 shares $262.78 million +9.3%N/A9.2 $28.94
5/29/20208,310,000 shares $224.95 million +0.7%N/A8.7 $27.07
5/15/20208,250,000 shares $216.81 million +2.0%N/A8 $26.28
4/30/20208,090,000 shares $187.04 million -1.0%N/A8.2 $23.12
4/15/20208,170,000 shares $184.07 million +5.3%N/A8.7 $22.53
3/31/20207,760,000 shares $194.08 million -8.9%N/A8 $25.01
3/13/20208,515,500 shares $188.45 million +4.1%N/A7.7 $22.13
2/28/20208,180,000 shares $160.16 million -5.4%N/A9.8 $19.58
2/14/20208,650,000 shares $187.79 million -3.2%N/A9.6 $21.71
1/31/20208,940,000 shares $200.35 million -1.2%N/A9.6 $22.41
1/15/20209,050,000 shares $244.26 million +3.7%N/A10.2 $26.99
12/31/20198,730,000 shares $247.50 million +1.5%N/A10.4 $28.35

EDIT Short Interest - Frequently Asked Questions

What is Editas Medicine's current short interest?

Short interest is the volume of Editas Medicine shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 16,060,000 shares of EDIT short. Learn More on Editas Medicine's current short interest.

What is a good short interest ratio for Editas Medicine?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EDIT shares currently have a short interest ratio of 7.0. Learn More on Editas Medicine's short interest ratio.

Which institutional investors are shorting Editas Medicine?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Editas Medicine: Wolverine Trading LLC, and Walleye Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Editas Medicine's short interest increasing or decreasing?

Editas Medicine saw a increase in short interest in November. As of November 30th, there was short interest totaling 16,060,000 shares, an increase of 0.9% from the previous total of 15,910,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Editas Medicine's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Editas Medicine: MeiraGTx Holdings plc (1.89%), Esperion Therapeutics, Inc. (15.63%), Monte Rosa Therapeutics, Inc. (23.93%), Cartesian Therapeutics, Inc. (19.85%), Organogenesis Holdings Inc. (11.86%), Verve Therapeutics, Inc. (28.32%), AnaptysBio, Inc. (27.33%), Alpha Teknova, Inc. (2.68%), Kodiak Sciences Inc. (2.73%), Korro Bio, Inc. (5.39%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Editas Medicine stock?

Short selling EDIT is an investing strategy that aims to generate trading profit from Editas Medicine as its price is falling. EDIT shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Editas Medicine?

A short squeeze for Editas Medicine occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EDIT, which in turn drives the price of the stock up even further.

How often is Editas Medicine's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EDIT, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:EDIT) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners